|
|
|
front |1 |2 |3 |4 |5 |6 |7 |8 |9 |10 |11 |12 |13 |14 |15 |16 |17 |18 |19 |20 |21 |22 |23 |24 |25 |26 |27 |28 |29 |30 |31 |32 |33 |34 |35 |36 |37 |38 |39 |40 |41 |42 |review |
 |
Controlled
Clinical Trials for the Treatment of Sputum Positive Pulmonary Tuberculosis
with Regimens Containing Ofloxacin (TRC Annual Report 1999-2000:24),
following durations of treatment ranging from the usual six months to just
three, the two-month culture conversion rates ranged from 92 percent to 98
percent. TB Monitor (06.01.01) Vol 8; No 6: P 65-67. |